NFKB1 and asthma: Modified HMW-HA also interacts with CD44 to inhibit NF-κB activation, dendritic cell maturation, and allergen-specific CD4 T-helper reaction, potentially providing therapeutic effects to asthma and allergic sinusitis [42].